Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

7 Keto Abiraterone Acetate

● Auf Lager

Katalog-Nr.::	VL830001
CAS-Nr.::	N/A
Summenformel::	C26H31NO3
Molare Masse::	405.53 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu 7 Keto Abiraterone Acetate

Parent drug

Abiraterone

IUPAC-Name

(3S, 8R, 9S, 10R, 13S, 14S)-10, 13-Dimethyl-7-oxo-17-(pyridin-3-yl)-2, 3, 4, 7, 8, 9, 10, 11, 12, 13, 14, 15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl Acetate

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

CC(O[C@H](CC1=C2)CC[C@]1(C)[C@@]3([H])CC[C@]4(C)C(C5=CC=CN=C5)=CC[C@@]4([H])[C@]3([H])C2=O)=O

Inchl

InChI=1S/C26H31NO3/c1-16(28)30-19-8-10-25(2)18(13-19)14-23(29)24-21-7-6-20(17-5-4-12-27-15-17)26(21,3)11-9-22(24)25/h4-6,12,14-15,19,21-22,24H,7-11,13H2,1-3H3/t19-,21-,22-,24-,25-,26+/m0/s1

Beschreibung

The compound 7 Keto Abiraterone Acetate is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines, including those from USP, EMA, JP, and BP. It is ideal for critical applications such as analytical method development, method validation (AMV), and quality control (QC), especially in the production of Abiraterone. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), this product delivers the precision required for reliable results. Additionally, it includes a detailed Structure Elucidation Report (SER), ensuring accuracy and dependability for advanced analytical purposes. 7 Keto Abiraterone Acetate or (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-7-oxo-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl Acetate, is an antiandrogen class and it is a used in the treatment a certain type of prostate cancer.

References

Thakur, Abhimanyu, et al. â€œAbiraterone Acetate in the Treatment of Prostate Cancer.â€ Biomedicine & Pharmacotherapy, vol. 101, May 2018, pp. 211â€“218, 10.1016/j.biopha.2018.02.067.